Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy

Muscle and Nerve

Volumn 55, Issue 4, 2017, Pages 520-525

  Lahoria, Rajat ^a   Pittock, Sean J ^a   Gadoth, Avi ^a   Engelstad, Janean K ^a   Lennon, Vanda A ^a   Klein, Christopher J ^a  

^a MAYO CLINIC   (United States)

Author keywords

channelopathy; immunotherapy; nerve biopsy; pain; voltage gated potassium antibody

Indexed keywords

AMITRIPTYLINE; ANTINEOPLASTIC AGENT; AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; CONTACTIN ASSOCIATED PROTEIN LIKE 2; CONTACTIN ASSOCIATED PROTEIN LIKE 2 AUTOANTIBODY; DEXAMETHASONE; DEXTROPROPOXYPHENE; GABAPENTIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEUCINE RICH GLIOMA INACTIVATED 1 PROTEIN; LEUCINE RICH GLIOMA INACTIVATED 1 PROTEIN AUTOANTIBODY; METHADONE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; POTASSIUM CHANNEL KV1.1; POTASSIUM CHANNEL KV1.2; POTASSIUM CHANNEL KV1.6; PREDNISONE; PROTEIN ANTIBODY; SHAKER POTASSIUM CHANNEL; UNCLASSIFIED DRUG; CNTNAP2 PROTEIN, HUMAN; LGI1 PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; POTASSIUM CHANNEL KCNQ1; PROTEIN;

ADULT; AGED; ALLODYNIA; ANALGESIA; ARTICLE; BURNING SENSATION; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL OUTCOME; CONTROLLED STUDY; CORRELATIONAL STUDY; CORTICOSTEROID THERAPY; DEMYELINATION; DISEASE ASSOCIATION; DISEASE DURATION; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERALGESIA; HYPESTHESIA; IMMUNOTHERAPY; INSOMNIA; LUNG ADENOCARCINOMA; MALE; MIDDLE AGED; MONONUCLEAR CELL; MOTOR NERVE CONDUCTION; NERVE BIOPSY; NERVE FIBER DEGENERATION; NEUROPATHIC PAIN; PAIN; PARESTHESIA; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SELF REPORT; SENSORY DYSFUNCTION; SENSORY NERVE CONDUCTION; SURAL NERVE; SYMPTOM; TREATMENT RESPONSE; VERY ELDERLY; WEAKNESS; BLOOD; COMPLICATION; FEMALE; GUILLAIN-BARRE SYNDROME; IMMUNOLOGY; NERVE CONDUCTION; PATHOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KCNQ1 POTASSIUM CHANNEL; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURAL CONDUCTION; PAIN; PROTEINS; SEVERITY OF ILLNESS INDEX; SURAL NERVE;

EID: 85013035516     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.25371     Document Type: Article

References (24)

1. Barber PA, Anderson NE, Vincent A. Morvan's syndrome associated with voltage-gated K + channel antibodies. Neurology 2000;54:771–772.
2. Hart IK, Waters C, Vincent A, Newland C, Beeson D, Pongs O, et al. Autoantibodies detected to expressed K + channels are implicated in neuromyotonia. Ann Neurol 1997;41:238–246.
3. Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, et al. Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 2013;70:229–234.
4. Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ. Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology 2012;79:1136–1144.
5. Meeusen JW, Lennon VA, Klein CJ. Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG. Neurology 2012;79:1824–1825.
6. Jacob S, Irani SR, Rajabally YA, Grubneac A, Walters RJ, Yazaki M, et al. Hypothermia in VGKC antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry 2008;79:202–204.
7. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701–712.
8. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734–2748.
9. Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69:303–311.
10. Zhou YD, Lee S, Jin Z, Wright M, Smith SE, Anderson MP. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat Med 2009;15:1208–1214.
11. Traka M, Goutebroze L, Denisenko N, Bessa M, Nifli A, Havaki S, et al. Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 2003;162:1161–1172.
12. Maddison P. Neuromyotonia. Clin Neurophysiol 2006;117:2118–2127.
13. Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, van den Berg RJ, et al. Acquired neuromyotonia: evidence for autoantibodies directed against K + channels of peripheral nerves. Ann Neurol 1995;38:714–722.
14. Nagado T, Arimura K, Sonoda Y, Kurono A, Horikiri Y, Kameyama A, et al. Potassium current suppression in patients with peripheral nerve hyperexcitability. Brain 1999;122:2057–2066.
15. Arimura K, Sonoda Y, Watanabe O, Nagado T, Kurono A, Tomimitsu H, et al. Isaacs' syndrome as a potassium channelopathy of the nerve. Muscle Nerve 2002;27(suppl 11):S55–58.
16. Bien CG, Vincent A, Barnett MH, Becker AJ, Blumcke I, Graus F, et al. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 2012;135:1622–1638.
17. Dyck PJ, Sherman WR, Hallcher LM, Service FJ, O'Brien PC, Grina LA, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol 1980;8:590–596.
18. Dyck PJ, Low PA, Windebank AJ. Axonal atrophy associated with segmental demyelination and axonal degeneration in human neuropathy. In: Schotland DL, editor. Disorders of the motor unit. New York: John Wiley & Sons; 1982. p 75–86.
19. Laurencin C, Andre-Obadia N, Camdessanche JP, Mauguiere F, Ong E, Vukusic S, Peter-Derex L, et al. Peripheral small fiber dysfunction and neuropathic pain in patients with Morvan syndrome. Neurology 2015;85:2076–2078.
20. Silva J, Sharma S, Hughes B, Yu YE, Cowell JK. Homozygous inactivation of the LGI1 gene results in hypomyelination in the peripheral and central nervous systems. J Neurosci Res 2010;88:3328–3336.
21. Vital A, Meissner WG, Canron MH, Martin-Negrier ML, Bezard E, Tison F, Vital C. Intra-axonal protein aggregation in the peripheral nervous system. J Periph Nerv Syst 2014;19:44–49.
22. Ogawa Y, Oses-Prieto J, Kim MY, Horresh I, Peles E, Burlingame AL, et al. ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons. J Neurosci 2010;30:1038–1048.
23. Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, et al. Gain of function Nanu1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 2012;71:26–39.
24. van Sonderen A, Schreurs MW, de Bruijn MA, Boukhrissi S, Nagtzaam MM, Hulsenboom ES, et al. The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology 2016;86:1692–1699.